{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:59:09Z","timestamp":1790258349515,"version":"4.1.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:p>This case report describes an unprecedented remission of ocular Myasthenia Gravis (MG) in a 3-year-old girl following a SARS-CoV-2 infection. Both MG and SARS-CoV-2 influence the cholinergic system, and this case underscores the importance of considering multiple factors in autoimmune disorders and the potential impact of viral infections on their course. The patient initially presented with ptosis and limited eye movement. Her diagnosis of seronegative MG was confirmed with abnormal visual evoked potentials and positive response to pyridostigmine. Her ptosis and limited extraocular muscle movement were intermittent until 2 years later when she tested positive for SARS-CoV-2 for which no antiviral medication was taken. Unexpectedly, her MG symptoms rapidly improved postinfection, leading to the cessation of pyridostigmine. This case highlights the complex interplay between MG, viral infections, and the influence of anti-acetylcholine receptor antibodies, second-hand smoke, and natural nicotinic agonists from the use of pyridostigmine on the cholinergic system.<\/jats:p>","DOI":"10.4103\/tjo.tjo-d-24-00087","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T04:00:15Z","timestamp":1738728015000},"page":"499-503","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Remission of myasthenia gravis following infection with SARS-CoV-2: A case report"],"prefix":"10.4103","volume":"16","author":[{"given":"Che-Yu","family":"Lin","sequence":"first","affiliation":[{"name":"Emory University School of Medicine, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Su","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann Yi-Chiun","family":"Chuang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, MacKay Memorial Hospital, Taipei, Taiwan"},{"name":"Department of Ophthalmology, MacKay Children\u2019s Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"key":"R1-20260924","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.3390\/jcm10112235","article-title":"Myasthenia gravis: Epidemiology, pathophysiology and clinical manifestations","volume":"10","author":"Dresser","year":"2021","journal-title":"J Clin Med"},{"key":"R2-20260924","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ana.22312","article-title":"Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis","volume":"69","author":"Higuchi","year":"2011","journal-title":"Ann Neurol"},{"key":"R3-20260924","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3390\/brainsci11081057","article-title":"Myasthenia gravis-an analysis of multimodal evoked potentials","volume":"11","author":"Dziadkowiak","year":"2021","journal-title":"Brain Sci"},{"key":"R4-20260924","first-page":"171","article-title":"Changes in the pattern reversal visual evoked potentials in myasthenia gravis","volume":"34","author":"Fotiou","year":"1994","journal-title":"Electromyogr Clin Neurophysiol"},{"key":"R5-20260924","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s41983-022-00516-3","article-title":"The relationship between myasthenia gravis and COVID-19: A systematic review","volume":"58","author":"Tugasworo","year":"2022","journal-title":"Egypt J Neurol Psychiatr Neurosurg"},{"key":"R6-20260924","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","article-title":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses","volume":"5","author":"Letko","year":"2020","journal-title":"Nat Microbiol"},{"key":"R7-20260924","doi-asserted-by":"crossref","first-page":"46","DOI":"10.7150\/ijbs.16404","article-title":"The protective effect of alpha 7 nicotinic acetylcholine receptor activation on critical illness and its mechanism","volume":"13","author":"Ren","year":"2017","journal-title":"Int J Biol Sci"},{"key":"R8-20260924","doi-asserted-by":"crossref","first-page":"5807","DOI":"10.3390\/ijms21165807","article-title":"Nicotinic cholinergic system and COVID-19: In silico identification of an interaction between SARS-CoV-2 and nicotinic receptors with potential therapeutic targeting implications","volume":"21","author":"Farsalinos","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R9-20260924","first-page":"572","article-title":"Clinical characteristics and treatment of juvenile myasthenia gravis-a single-center experience","volume":"11","author":"Maeda","year":"2024","journal-title":"Children (Basel)"},{"key":"R10-20260924","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3390\/ijms23020672","article-title":"Disorders of the cholinergic system in COVID-19 era-a review of the latest research","volume":"23","author":"Kopa\u0144ska","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R11-20260924","doi-asserted-by":"crossref","first-page":"33","DOI":"10.5802\/crbiol.8","article-title":"A nicotinic hypothesis for COVID-19 with preventive and therapeutic implications","volume":"343","author":"Changeux","year":"2020","journal-title":"C R Biol"},{"key":"R12-20260924","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1474-4422(14)70201-7","article-title":"Congenital myasthenic syndromes: Pathogenesis, diagnosis, and treatment","volume":"14","author":"Engel","year":"2015","journal-title":"Lancet Neurol"}],"container-title":["Taiwan Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.TJO-D-24-00087","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:01:45Z","timestamp":1790254905000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.TJO-D-24-00087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/tjo.tjo-d-24-00087","relation":{},"ISSN":["2211-5056","2211-5072"],"issn-type":[{"value":"2211-5056","type":"print"},{"value":"2211-5072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]},"assertion":[{"value":"2024-07-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}